What is the Starpharma Holdings (ASX: SPL) share price?
The SPL share price is $0.695, up 0.00% for the day, based on the latest available ASX market data.
What is Starpharma Holdings's market capitalisation?
Starpharma Holdings has a market capitalisation of $292.5M, making it the 574th-largest security listed on the ASX.
Does Starpharma Holdings pay a dividend?
SPL does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
What is SPL's P/E ratio?
Starpharma Holdings trades on a trailing price-to-earnings (P/E) ratio of 27.58, based on its current share price and most recent reported earnings.
Is Starpharma Holdings profitable?
Yes. In its most recent reported period (ending 31 Dec 2025), SPL reported revenue of $10.8M and a net profit of $1.4M.
How many SPL shares are on issue?
Starpharma Holdings has approximately 420,928,000 shares on issue, based on its market capitalisation of $292.5M and current share price.
What sector is Starpharma Holdings in?
Starpharma Holdings is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Starpharma Holdings list on the ASX?
Starpharma Holdings listed on the Australian Securities Exchange on 27 Sept 2000.
ONE
EMV
RCE
ATH
ACW
NYR
ILA
ALA
